A Bayesian phase I/II trial design for immunotherapy (Q4559685)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Bayesian phase I/II trial design for immunotherapy |
scientific article; zbMATH DE number 6988477
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A Bayesian phase I/II trial design for immunotherapy |
scientific article; zbMATH DE number 6988477 |
Statements
A Bayesian Phase I/II Trial Design for Immunotherapy (English)
0 references
4 December 2018
0 references
Bayesian adaptive design
0 references
dose finding
0 references
immune response
0 references
immunotherapy
0 references
phase I/II trial
0 references
risk-benefit tradeoff
0 references
0 references
0 references
0 references
0.738849401473999
0 references
0.7287966012954712
0 references
0.7181078791618347
0 references
0.7142192721366882
0 references
